A randomized Phase I study of the safety, tolerability, pharmacokinetics and pharmacodynamics of BI 456906, a dual glucagon receptor/glucagon-like peptide-1 receptor agonist, in healthy Japanese men with overweight/obesity
Table of Contents Why GLP-1 Medications Can Cause Vomiting Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications increasingly prescribed for type 2 diabetes management and, more recently, for weight management in adults with obesity
They mention significant weight loss and better blood sugar control
doi: 10.1016/j.jacc.2024.08.004 [DOI] [PubMed] [Google Scholar] 152.Deanfield J, Verma S, Scirica BM, et al
Supporting Long-Term Success The combination of weight loss injections and meal replacements not only supports initial weight loss but also helps in developing sustainable habits for long-term success